Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Fisher

Showing results (191-200 of 216) with videos related to

Pageof 22
Sort By:
Plos One|January 7, 2011
Rising population cost for treating people living with HIV in the UK, 1997-2013Sundhiya Mandalia, Roshni Mandalia, Gary Lo, et al.
AIDS (London, England)|March 15, 2005
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practiceAndrew N Phillips, David Dunn, Caroline Sabin, et al.
Clinical Medicine (London, England)|November 5, 2009
Testing for HIV: concise guidanceAdrian Palfreeman, Martin Fisher, Ed Ong, et al.
Cytokine|May 2, 2016
CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSFSam Nightingale, Benedict D Michael, Martin Fisher, et al.
The Journal of Infectious Diseases|January 27, 2012
Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?Mark Gompels, David T Dunn, Andrew Phillips, et al.
AIDS (London, England)|January 16, 2008
Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?Loveleen K Bansi, Andrew A Benzie, Andrew N Phillips, et al.
AIDS (London, England)|February 22, 2014
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapyMargaret T May, Mark Gompels, Valerie Delpech, et al.
HIV Clinical Trials|June 27, 2006
Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment-experienced, HIV-infected individuals: recent data and consensus recommendationsMike Youle, Schlomo Staszweski, Bonaventura Clotet, et al.
AIDS (London, England)|December 17, 2013
Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppressionJemma L O'Connor, Colette J Smith, Fiona C Lampe, et al.
Antiviral Therapy|September 9, 2011
Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC StudyTristan J Barber, Anna Maria Geretti, Jane Anderson, et al.
Pageof 22

Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Plos One|January 7, 2011
Rising population cost for treating people living with HIV in the UK, 1997-2013Sundhiya Mandalia, Roshni Mandalia, Gary Lo, et al.
AIDS (London, England)|March 15, 2005
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practiceAndrew N Phillips, David Dunn, Caroline Sabin, et al.
Clinical Medicine (London, England)|November 5, 2009
Testing for HIV: concise guidanceAdrian Palfreeman, Martin Fisher, Ed Ong, et al.
Cytokine|May 2, 2016
CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSFSam Nightingale, Benedict D Michael, Martin Fisher, et al.
The Journal of Infectious Diseases|January 27, 2012
Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?Mark Gompels, David T Dunn, Andrew Phillips, et al.
AIDS (London, England)|January 16, 2008
Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?Loveleen K Bansi, Andrew A Benzie, Andrew N Phillips, et al.
AIDS (London, England)|February 22, 2014
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapyMargaret T May, Mark Gompels, Valerie Delpech, et al.
HIV Clinical Trials|June 27, 2006
Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment-experienced, HIV-infected individuals: recent data and consensus recommendationsMike Youle, Schlomo Staszweski, Bonaventura Clotet, et al.
AIDS (London, England)|December 17, 2013
Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppressionJemma L O'Connor, Colette J Smith, Fiona C Lampe, et al.
Antiviral Therapy|September 9, 2011
Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC StudyTristan J Barber, Anna Maria Geretti, Jane Anderson, et al.
Pageof 22